Epigenomics services provider Epinomics, co-founded by Stanford University faculty and alumni, has been bought by 10x Genomics in a transaction which enables StartX to exit.
Epinomics, a US-based epigenomics services spinout of Stanford University, was acquired by genomic sequencing tool developer 10x Genomics on Wednesday providing an exit for the Stanford-StartX accelerator.
Founded in 2013, Epinomics has developed an epigenomics technology and analytics platform that helps researchers uncover biomarkers for therapeutic projects by exploiting a sequencing technique called Atac-seq, co-invented in 2013 by some of Epinomics’ founding team.
Epigenomics generally explores factors that activate or deactivate genes across a single cell’s entire genetic material, which…
